These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 9872320)
21. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
22. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells. Robson NC; Donachie AM; Mowat AM Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931 [TBL] [Abstract][Full Text] [Related]
23. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways. Demotz S; Matricardi PM; Irle C; Panina P; Lanzavecchia A; Corradin G J Immunol; 1989 Dec; 143(12):3881-6. PubMed ID: 2480377 [TBL] [Abstract][Full Text] [Related]
24. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. Serwold T; Shastri N J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012 [TBL] [Abstract][Full Text] [Related]
25. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Brocke P; Armandola E; Garbi N; Hämmerling GJ Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938 [TBL] [Abstract][Full Text] [Related]
26. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens. Cheng PC; Steele CR; Gu L; Song W; Pierce SK J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163 [TBL] [Abstract][Full Text] [Related]
27. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells. Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749 [TBL] [Abstract][Full Text] [Related]
28. Antigen presentation. A protease draws first blood. Bogyo M; Ploegh HL Nature; 1998 Dec; 396(6712):625, 627. PubMed ID: 9872306 [No Abstract] [Full Text] [Related]
29. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084 [TBL] [Abstract][Full Text] [Related]
30. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588 [TBL] [Abstract][Full Text] [Related]
31. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
32. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related]
33. A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. Buus S; Werdelin O J Immunol; 1986 Jan; 136(2):452-8. PubMed ID: 3079785 [TBL] [Abstract][Full Text] [Related]
34. Catheptic processing of protein antigens: enzymic and molecular aspects. van der Drift AC; van Noort JM; Krüse J Semin Immunol; 1990 Jul; 2(4):255-71. PubMed ID: 1983339 [TBL] [Abstract][Full Text] [Related]
35. Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis. Nepal RM; Mampe S; Shaffer B; Erickson AH; Bryant P Int Immunol; 2006 Jun; 18(6):931-9. PubMed ID: 16636015 [TBL] [Abstract][Full Text] [Related]
36. Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. Shirahama-Noda K; Yamamoto A; Sugihara K; Hashimoto N; Asano M; Nishimura M; Hara-Nishimura I J Biol Chem; 2003 Aug; 278(35):33194-9. PubMed ID: 12775715 [TBL] [Abstract][Full Text] [Related]
37. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII. Antoniou AN; Watts C Eur J Immunol; 2002 Feb; 32(2):530-40. PubMed ID: 11828370 [TBL] [Abstract][Full Text] [Related]
38. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. Burster T; Beck A; Tolosa E; Marin-Esteban V; Rötzschke O; Falk K; Lautwein A; Reich M; Brandenburg J; Schwarz G; Wiendl H; Melms A; Lehmann R; Stevanovic S; Kalbacher H; Driessen C J Immunol; 2004 May; 172(9):5495-503. PubMed ID: 15100291 [TBL] [Abstract][Full Text] [Related]
39. Creation versus destruction of T cell epitopes in the class II MHC pathway. Watts C; Moss CX; Mazzeo D; West MA; Matthews SP; Li DN; Manoury B Ann N Y Acad Sci; 2003 Apr; 987():9-14. PubMed ID: 12727619 [TBL] [Abstract][Full Text] [Related]
40. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain. Sexton KB; Witte MD; Blum G; Bogyo M Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]